The impact of preprocedural hemoglobin A1c on the efficacy of sirolimus-eluting and paclitaxel-eluting stents-Reference-Cited by-同舟云学术

The impact of preprocedural hemoglobin A1c on the efficacy of sirolimus-eluting and paclitaxel-eluting stents

Published:2012-01-24 Issue:2 Volume:27 Page:72-83
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Sawai Toshiki,Miyahara Masatoshi,Nakajima Hiroshi,Nakamori Shiro,Sakai Masataka,Tamada Hiroya,Tanigawa Takashi,Yamada Norikazu,Nakamura Mashio,Ito Masaaki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12928-012-0095-2.pdf

Reference46 articles.

1. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: Part II: Recent advances in coronary revascularization. J Am Coll Cardiol. 2007;49:643–56.

2. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 1998;32:1866–73.

3. Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008;51:708–15.

4. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005;112:2175–83.

5. Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, et al. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry. Circulation. 2008;117:923–30.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer;Oncology Reports;2021-03-31

2. Glycosylated hemoglobin levels and clinical outcomes in diabetic patients receiving percutaneous coronary interventions: A meta-analysis of cohort studies;International Journal of Cardiology;2015-07

3. Five-year clinical outcomes after implantation of sirolimus-eluting stents in patients with and without diabetes mellitus;Cardiovascular Intervention and Therapeutics;2012-07-14